These benefits, together with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 assist the concept of concentrating on ACKR3 as a unique solution to modulate the opioid process, which could open up new therapeutic avenues for opioid-related Conditions. Identify your collection: Title https://cyrilf344xby0.ourabilitywiki.com/user